Recombinant Human GNRH2 Protein: Handling & Usage Protocol

Recombinant Human GNRH2 Protein is a biologically active neuropeptide used in reproductive biology and neuroendocrinology research, requiring careful reconstitution and storage to maintain full biological activity.

Product Name

Recombinant Human GNRH2 Protein

SKU

rp368057

Protein Origin

Human (Homo sapiens)

Recommended Storage

-20°C or -80°C; avoid repeated freeze-thaw cycles

Application

Reproductive biology, neuroendocrinology, in vitro bioassays

Form

Lyophilized or liquid (confirm with datasheet)

Background and Biological Overview

Gonadotropin-releasing hormone 2 (GNRH2), also known as GnRH-II or mammalian GnRH-II, is a highly conserved decapeptide belonging to the gonadotropin-releasing hormone family. It is structurally distinct from the classical GNRH1 and is expressed in multiple tissues including the brain, kidney, and reproductive organs. GNRH2 is believed to play roles in modulating reproductive behavior, energy homeostasis, and potentially in the regulation of gonadotropin secretion via a separate receptor subtype. Recombinant Human GNRH2 Protein (rp368057) provides researchers with a reliable, consistent source of this neuropeptide for in vitro and in vivo experimental applications in neuroendocrinology and reproductive biology.

Materials and Equipment Required

• Recombinant Human GNRH2 Protein (rp368057, Aladdin Scientific)
• Sterile deionized water or recommended reconstitution buffer (e.g., PBS, pH 7.4)
• Low-binding microcentrifuge tubes (1.5 mL)
• Calibrated micropipettes and sterile tips
• Microcentrifuge
• -20°C and/or -80°C freezer
• Ice bucket
• Laminar flow hood or biosafety cabinet (recommended)
• Spectrophotometer or BCA/Bradford assay reagents for concentration verification (optional)

Step-by-Step Reconstitution and Handling Protocol

Step 1 – Preparation: Allow the vial of Recombinant Human GNRH2 Protein to equilibrate to room temperature for approximately 5–10 minutes before opening. This minimizes condensation inside the vial.

Step 2 – Reconstitution: Add the recommended volume of sterile reconstitution buffer (refer to the product datasheet for the specific volume and buffer) slowly along the inner wall of the vial. Do not vortex vigorously; instead, gently swirl or pipette up and down to dissolve the lyophilized material completely. If the product is supplied in liquid form, proceed directly to the aliquoting step.

Step 3 – Centrifugation: Briefly centrifuge the reconstituted vial at low speed (e.g., 300–500 × g, 30 seconds) to collect any residual material from the vial walls and cap.

Step 4 – Aliquoting: Immediately prepare single-use aliquots in low-binding tubes to avoid repeated freeze-thaw cycles. Label each aliquot with the protein name, concentration, date, and lot number.

Step 5 – Storage: Store aliquots at -20°C for short-term use (up to 1 month) or at -80°C for long-term storage. Always refer to the product-specific datasheet for confirmed storage conditions and shelf life.

Step 6 – Working Dilution: Thaw a single aliquot on ice immediately before use. Prepare working dilutions in the appropriate assay buffer. Do not refreeze thawed aliquots.

Quality Control and Troubleshooting

Verifying Protein Integrity: Upon reconstitution, the solution should be clear and colorless to slightly opalescent with no visible aggregates. Turbidity or visible particulates may indicate protein aggregation; in this case, centrifuge at higher speed (e.g., 10,000 × g, 5 minutes at 4°C) and use the supernatant.

Concentration Verification: If accurate quantification is required, use a BCA or Bradford protein assay with a BSA standard curve, or measure absorbance at 280 nm using the protein's extinction coefficient (refer to the datasheet).

Activity Verification: Biological activity should be confirmed using an appropriate cell-based assay or receptor-binding assay relevant to GNRH2 signaling (e.g., cAMP accumulation assay). A positive control with a validated lot is recommended.

Common Issues:

• Low activity: Check storage history for temperature excursions; verify buffer composition and pH; confirm working concentration is within the validated range.
• Aggregation: Avoid freeze-thaw cycles; consider adding carrier protein (e.g., 0.1% BSA) to dilution buffer for dilute solutions.
• Inconsistent results: Ensure single-use aliquots; verify assay buffer compatibility.

Safety, Disposal, and Regulatory Considerations

Safety: Recombinant Human GNRH2 Protein is intended for research use only and is not approved for therapeutic, diagnostic, or veterinary use. Handle all recombinant proteins with standard laboratory precautions: wear appropriate personal protective equipment (gloves, lab coat, eye protection). Although this protein does not present a known biohazard at research quantities, follow your institution's biosafety guidelines.

Disposal: Dispose of all protein solutions and contaminated materials in accordance with your institution's chemical and biological waste disposal regulations. Autoclave or chemically inactivate biological waste before disposal where required.

Regulatory: This product is for in vitro research use only (RUO). Not for use in humans or animals. Users are responsible for compliance with all applicable local, national, and international regulations governing the use of recombinant proteins in research.

Frequently asked questions

What reconstitution buffer is recommended for Recombinant Human GNRH2 Protein?

The recommended reconstitution buffer and volume are specified in the product-specific datasheet supplied with each vial of rp368057. Sterile PBS (pH 7.4) is commonly used for recombinant neuropeptides; however, always consult the datasheet to confirm the optimal buffer, volume, and final concentration for your specific lot.

How should Recombinant Human GNRH2 Protein be stored to maintain stability?

Store lyophilized protein at -20°C or -80°C upon receipt. After reconstitution, prepare single-use aliquots and store at -80°C for long-term stability. Avoid repeated freeze-thaw cycles, as these can lead to protein aggregation and loss of biological activity. Adding a carrier protein such as 0.1% BSA to working dilutions may improve stability for highly dilute solutions.

What applications is Recombinant Human GNRH2 Protein suitable for?

Recombinant Human GNRH2 Protein (rp368057) is suitable for research applications including in vitro bioassays, receptor binding studies, cell stimulation experiments, and investigation of reproductive and neuroendocrine signaling pathways. Always validate the protein's activity in your specific assay system using appropriate positive controls.

How can I verify the biological activity of Recombinant Human GNRH2 Protein?

Biological activity can be assessed using a cell-based assay relevant to GNRH2 signaling, such as a cAMP accumulation assay in cells expressing the GnRH-II receptor, or a receptor-binding competition assay. Refer to the product datasheet for any lot-specific activity data provided by Aladdin Scientific, and include a validated positive control in each experiment.

References

1. Millar RP. GnRHs and GnRH receptors. Animal Reproduction Science. 2005;88(1-2):5-28. doi:10.1016/j.anireprosci.2005.05.032
2. Carolyn A. Flanagan et al. Interrogating the function of GnRH-II and its receptor. Frontiers in Neuroendocrinology. 2007.
3. Grundker C, Gunthert AR, Emons G. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. Journal of Clinical Endocrinology & Metabolism. 2002.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.